Literature DB >> 26597143

Efficacy of medicinal essential oils against pathogenic Malassezia sp. isolates.

A R Khosravi1, H Shokri2, S Fahimirad3.   

Abstract

OBJECTIVES: The purposes of this study were to evaluate the distribution pattern and population size of Malassezia species in dogs with atopic dermatitis (AD) and the inhibitory efficacy of Zataria multiflora, Thymus kotschyanus, Mentha spicata, Artemisia sieberi, Rosmarinus officinalis and Heracleum persicum essential oils against pathogenic Malassezia isolates.
METHODS: The samples were collected from 5 different anatomical sites of 33 atopic dogs and cultured onto modified Dixon agar (MDA) and Sabouraud dextrose agar (SDA) media. The essential oil extraction was performed by steam distillation using Clevenger system. Anti-Malassezia efficacy of medicinal essential oils and standard drugs was evaluated using broth microdilution method.
RESULTS: A total of 103 yeast colonies were isolated from dogs with AD. Eight different Malassezia species were identified as follows: Malassezia pachydermatis (81.4%), M. globosa (7.8%), M. restricta (3.9%), M. sloofiae (2.9%), M. furfur (1%), M. nana (1%), M. obtusa (1%) and M. sympodialis (1%). The most and least infected sites were: anal (21.2%) and ear (10.6%) respectively. M. pachydermatis was the most frequent Malassezia species isolated from both skin and mucosa of dogs with AD. Antifungal susceptibility test revealed the inhibitory efficacy of essential oils on pathogenic Malassezia isolates with minimum inhibitory concentration (MIC(90)) values ranging from 30 to 850 μg/mL. Among the tested oils, Z. multiflora and T. kotschyanus exhibited the highest inhibitory effects (P<0.05).
CONCLUSION: The essential oils of Z. multiflora and T. kotschyanus showed strong antifungal activity against pathogenic Malassezia species tested.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Atopique; Chien; Dermatite atopique; Dog; Essential oils; Huiles essentielles; Malassezia; Malassezia pachydermatis; Malassezia sp.

Mesh:

Substances:

Year:  2015        PMID: 26597143     DOI: 10.1016/j.mycmed.2015.10.012

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  7 in total

1.  Antifungal in vitro Activity of Essential Oils against Clinical Isolates of Malassezia pachydermatis from Canine Ears: A Report from a Practice Laboratory.

Authors:  Doris Bismarck; Anika Dusold; Anton Heusinger; Elisabeth Müller
Journal:  Complement Med Res       Date:  2019-11-27       Impact factor: 1.211

Review 2.  Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases.

Authors:  Ané Orchard; Sandy van Vuuren
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-04       Impact factor: 2.629

3.  How do essential oil composition and phenolic acid profile of Heracleum persicum fluctuate at different phenological stages?

Authors:  Saeid Hazrati; Saeed Mollaei; Hossein Rabbi Angourani; Seyyed Jaber Hosseini; Mojde Sedaghat; Silvana Nicola
Journal:  Food Sci Nutr       Date:  2020-09-28       Impact factor: 2.863

Review 4.  Use of Essential Oils in Veterinary Medicine to Combat Bacterial and Fungal Infections.

Authors:  Valentina Virginia Ebani; Francesca Mancianti
Journal:  Vet Sci       Date:  2020-11-30

5.  In Vitro Antibacterial Activity of Manuka (Leptospermum scoparium J.R. et G. Forst) and winter Savory (Satureja montana L.) Essential Oils and Their Blends against Pathogenic E. coli Isolates from Pigs.

Authors:  Filippo Fratini; Mario Forzan; Barbara Turchi; Simone Mancini; Giuseppe Alcamo; Francesca Pedonese; Luisa Pistelli; Basma Najar; Maurizio Mazzei
Journal:  Animals (Basel)       Date:  2020-11-24       Impact factor: 2.752

Review 6.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

7.  Antifungal Carvacrol Loaded Chitosan Nanoparticles.

Authors:  Alberto Vitali; Annarita Stringaro; Marisa Colone; Alexandra Muntiu; Letizia Angiolella
Journal:  Antibiotics (Basel)       Date:  2021-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.